Summary
No overall score for this company yet.
What speaks for it
- It earns 54 USD a year on every 100 USD of invested capital.
What to watch
- Revenue fell by 98% a year over the last 3 years.
- It passes only 0 of the 9 points of the Piotroski financial health test.
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Score in detailPrice
Is it expensive?
Is it growing?
Revenue (USD)
Diluted EPS (USD)
Revenue fell by 98% a year over the last 3 years.
Growth in detailDoes it make money?
Over the last 12 months it made a loss of $38.0K.
Profitability in detailIs it financially healthy?
Debt is a burdenOver the last 12 months it spent more cash than it brought in. Its debt is larger than its cash.
Financial health in detailDoes it pay a dividend?
NoIt pays no dividend.
Dividends in detailWhat do analysts expect?
No coverageNo analyst covers this stock.
Analysts in detailWhat does it earn on?
By product
The company reports no revenue by product.
By region
The company reports no revenue by region.